Purpose Pretreatment with volatile anesthetics has been demonstrated to exert cardioprotective effects. The purpose of this study was to examine the effect of emulsified isoflurane, a new formulation of isoflurane in lipid emulsion, administered intravenously in an ischemia and reperfusion model of myocardial injury. Methods Thirty-two Sprague Dawley rats of both sexes were subjected to 30 min of myocardial ischemia followed by 180 min of reperfusion. Each was assigned to one of four pretreatment groups to receive an isovolumetric intravenous infusion of saline: control group, 30% intralipid group, 8% emulsified isoflurane 2 ml kg -1 group, and sham group (each group, n = 8). The vehicles were administered at a constant rate for 30 min and then discontinued 30 min before left anterior descending coronary artery occlusion. The cardioprotective effects were examined by determining hemodynamics, infarct size, enzyme activity, and cardiomyocytic apoptosis. Results Pretreatment with emulsified isoflurane 2 ml kg -1 (P = 0.000) significantly reduced infarct size (22.6 ± 2.2%) compared with control (34.8 ± 2.3%) and 30% intralipid (31.1 ± 2.9%). When compared with the control and intralipid groups, emulsified isoflurane increased Bcl-2 expression while decreasing Bax and Caspase-3 expression and enhancing Bcl-2/Bax ratios. The apoptotic index in the emulsified isoflurane treatment group showed a significant reduction compared with that in the control group (P = 0.000) and the intralipid group (P = 0.001). In addition, the serum levels of lactate dehydrogenase and creatine kinase were markedly reduced in the emulsified isoflurane treatment group compared with the control and intralipid groups (lactate dehydrogenase, P = 0.015 vs. control; creatine kinase, P = 0.000 vs. control and intralipid). Conclusion These data support a cardioprotective effect of intravenous emulsified isoflurane against myocardial ischemia and reperfusion injury, which are mediated, at least in part, by the inhibition of apoptosis and cell damage.
RésuméObjectif Il a e´te´de´montre´que les agents anesthe´siques volatils exercent un effet cardioprotecteur lorsqu'ils sont administre´s en traitement pre´ventif. L'objectif de cette e´tude e´tait d'examiner l'effet d'une e´mulsion d'isoflurane, une nouvelle formulation d'isoflurane en e´mulsion lipidique, administre´e par voie intraveineuse dans un mode`le d'ische´mie reperfusion de le´sion myocardique. Méthode Trente-deux rats Sprague Dawley des deux sexes ont e´te´soumis a`30 min d'ische´mie myocardique suivie de 180 min de reperfusion. Chaque rat a e´te´rand-omise´dans l'un des quatre groupes de pre´traitement suivants, recevant tous une perfusion intraveineuse isovolume´trique de solution saline : groupe te´moin, groupe intralipide 30%, groupe e´mulsion d'isoflurane 8% 2 mL kg -1 , et groupe sans intervention (pour chaque groupe, n = 8). Les ve´hicules ont e´te´administre´s à un taux constant durant 30 min puis interrompu 30 min avant l'occlusion de l'arte`re coronaire descendante ante´rieure